CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
hydrogen inhalation, 4% concentration, given via nasal cannulaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05476575
NCT05476575N/ACompleted
CompareCT.gov

The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines

Fu Jen Catholic University Hospital·interventional·Posted Jul 27, 2022·Updated Feb 17, 2026

In Brief

A clinical study evaluating hydrogen inhalation, 4% concentration, given via nasal cannula for Pain, Acute. Completed, enrolled 37 participants across 1 site.

Detailed Summary

To understand the impact of perioperative hydrogen inhalation on post-operative pain control and serum inflammation markers

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Acute
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 27, 2022
Enrollment StartOct 28, 2021
Primary CompletionDec 30, 2024
Study CompletionFeb 28, 2025
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 3.9 years ago

Interventions

hydrogen inhalation, 4% concentration, given via nasal cannulaother

4% hydrogen inhalation via nasal cannula perioperatively